Sentences with phrase «placebo treatment using»

«Cold water in the left ear significantly increased patients» insight and awareness of their schizophrenia, which we measured 30 minutes after the test, compared with the sham or placebo treatment using room temperature water,» says Dr. Gerretsen.

Not exact matches

Placebos are used to help accurately measure clinical responses / outcomes when studying the effects of medications, therapies, and other treatments.

In this new study and for the first time, scientists used functional magnetic resonance imaging (fMRI) combined with a standard clinical trial design to derive an unbiased brain - based neurological marker to predict analgesia associated with placebo treatment in patients with chronic knee osteoarthritis pain.

In a related Editor's Note, Deborah Grady, M.D., M.P.H., a deputy editor of JAMA Internal Medicine, writes: «It is possible that treatment beyond one year would result in better outcomes, but these data provide no support for use of higher - dose cholecalciferol replacement therapy or indeed any dose of cholecalciferol compared with placebo.»

TRINOVA - 2 is evaluating pegylated liposomal doxorubicin in combination with either placebo or trebananib in previously treated patients with ovarian cancer while TRINOVA - 3, also known as ENGOT - Ov2 and Gynecologic Oncology Group — 3001, is studying the use of trebananib in front - line treatment adding it to carboplatin / paclitaxel.

Dr Jones, said: «This new meta - analysis shows that baclofen is no more effective than placebo on a range of key outcome measures, suggesting that the current increasing use of baclofen as a treatment for alcohol use disorders is premature.»

The study, «Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double - blind, placebo - controlled trail,» published online will change how clinicians understand this treatment and encourage them to consider its early use before the condition causes severe emphysema.

Using a sample of 10 resistance - trained men in their early 20s, protein supplementation consisted of 3 treatment groups: whey protein isolate, soy protein isolate, or a maltrodextrin placebo control.

Some trial participants were randomly assigned to use inhalers daily while some used them intermittently; some received placebos and some received no treatment.

The patients used each treatment (candesartan, propranolol or placebo) for 12 weeks, and also underwent four weeks before start and between the treatment periods without any medication at all.

Yet concerns persist and many are «overinflated,» they add, and list recent studies supporting the use of lithium, once labelled a «toxic placebo,» and antipsychotics, and treatments for mood disorders.

They also found some evidence supporting the use of techniques such as acupuncture and spinal manipulation for acute and chronic pain — although it should be noted that several researchers have questioned whether these treatments are superior to placebo or sham therapies.

Among cigarette smokers not willing or able to quit smoking in the next month but willing to reduce with the goal of quitting in the next 3 months, use of the nicotine addiction medication varenicline for 24 weeks compared with placebo produced greater reductions in smoking prior to quitting and increased smoking cessation rates at the end of treatment and at 1 year, according to a study in the February 17 issue of JAMA.

A pooled analysis of data from two randomised trials comparing vitamin E versus placebo, and the placebo group from another trial comparing vitamin E use versus non-use, demonstrates that the efficacy of vitamin E is comparable to other treatments for NASH, including pioglitazone, metformin and obeticholic acid.

The researchers found that the addition of vitamin D3 to ciclesonide did not significantly reduce the rate of first treatment failure (a composite outcome of decline in lung function and increases in use of beta - agonists, systemic steroids, and health care utilization) compared with placebo; 28 percent and 29 percent of participants in each group, respectively, experienced at least 1 treatment failure during 28 weeks.

These would make use of factors contributing to the placebo effect, applying them specifically to the treatment of depression.

Instead, the team chose only studies that were placebo - controlled, used tDCS as a daily medical treatment, and involved at least 10 participants.

«Both physical functioning and quality of life are severely affected, and while many treatments are used to relieve symptoms and try to get the disease under control, this largest set of placebo - controlled information to date clearly shows that improvement can result for patients.»

The drugs and placebo were provided to paramedics in indistinguishable boxes containing three syringes, each containing a third of the maximum total dose, to ensure that neither patients nor care providers knew which treatment was used for a given patient.

In many trials, some participants are randomly assigned to the «control» group and receive an inactive «placebo» treatment or a standard intervention currently in use; sometimes the control subjects are later given a chance to try the experimental treatment.

Placebos are rarely used in cancer treatment clinical trials.

The study looked at the effect of dietary supplementation using 2,000 international units of nonprescription vitamin E daily in a large group of elderly Alzheimer's patients and compared their results over an average of around two years to similar patients who received a placebo, a pharmaceutical marketed as a «treatment» for Alzheimer's disease (memantine), or a combination of memantine along with vitamin E.

The men were treated with a Maca extract of 2400 mg or a placebo, and the effect of the Maca treatment was tested using the International Index of Erectile Function (IIEF - 5) before and after 12 weeks of treatment.

BOOKS (67) http://www.amazon.com/Bioelectromagnetic-Healing-Rationale-its-Use/dp/0964107058 Bioelectromagnetic Healing: A Rationale for its Use by Thomas Valone 2003 (68) http://www.amazon.com/Energy-Medicine-Scientific-James-Oschman/dp/0443062617 Energy Medicine: The Scientific Basis by James L. Oschman 2000 Therapeutic Uses of Pulsed EMF (69)(70)(71)(72)(73)(74)(75) http://ajp.psychiatryonline.org/cgi/content/full/163/1/88 A Randomized, Controlled Trial of Sequential Bilateral Repetitive Transcranial Magnetic Stimulation for Treatment - Resistant Depression, Am J Psychiatry 163:88 - 94, January 2006 (70) http://www.ondamed.net/publication/html/en/article15.html Impulse magnetic - field therapy for migraine and other headaches: a double - blind, placebo - controlled study.

Extensive placebo - controlled clinical trials will be needed before metformin can be used as a standard cancer treatment.

When no diagnosis was found, a placebo treatment was used.

Sixteen systematic reviews provided data on 17 comparisons with inactive interventions (placebo, sham interventions or waiting list).30 — 32 35 — 37 39 — 43 45 — 50 figure 2 provides an overview of treatment effects of non-pharmacological and common pharmacological treatments for MDD when compared with inactive interventions using standardised mean differences.

The use of a single antidepressant in an open - trial design without a placebo control did not allow us to rule out that maternal remission was due to nonspecific treatment effects or whether the relation of maternal remission to children's outcomes may have been different if another medication or psychotherapy had been used.

Hollander et al used a double blind, placebo controlled design to examine the efficacy of a 10 week treatment of lithium on the clinical and cognitive features of gambling in pathological gamblers with bipolar spectrum disorder.

Compared with placebo, treatment of depressed systolic heart failure patients with escitalopram will result in a significant improvement in symptoms of depression at six months, when measured using the Hamilton Depression Rating Scale.

Compared with placebo, treatment of depressed systolic heart failure patients with escitalopram will result in a significant improvement in symptoms of depression at six months, when measured using the Cardiac Depression Scale.

This study (NIDA #R01DA025616) is a randomized clinical trial (RCT) that will compare an experimental treatment (OutPatient Treatment for Adolescents) to an «active placebo» on key indices (drug use; mental health; behavioral, school, peer, and family functioning; and consumer satisfaction) from pre-treatment through 18 months in order to evaluate its efficacy for youth referred to outpatient treatment of co-occurring substance use and internalizing treatment (OutPatient Treatment for Adolescents) to an «active placebo» on key indices (drug use; mental health; behavioral, school, peer, and family functioning; and consumer satisfaction) from pre-treatment through 18 months in order to evaluate its efficacy for youth referred to outpatient treatment of co-occurring substance use and internalizing Treatment for Adolescents) to an «active placebo» on key indices (drug use; mental health; behavioral, school, peer, and family functioning; and consumer satisfaction) from pre-treatment through 18 months in order to evaluate its efficacy for youth referred to outpatient treatment of co-occurring substance use and internalizing treatment through 18 months in order to evaluate its efficacy for youth referred to outpatient treatment of co-occurring substance use and internalizing treatment of co-occurring substance use and internalizing problems.

Two treatment conditions and two control groups were used in a variant of the Solomon four - group study design that included an attention - placebo manipulation instead of a posttest - only control group.